Switch to: References

Add citations

You must login to add citations.
  1. The Grand Challenge of Human Health: A Review and an Urgent Call for Business–Health Research.Remy Balarezo, Bryan W. Husted, Ivan Montiel & Junghoon Park - 2022 - Business and Society 61 (5):1353-1415.
    Considering the urgency of addressing grand challenges that affect human health and achieving the ambitious health targets set by the United Nations’ Sustainable Development Goals, the role of business in improving health has become critical. Yet, our systematic review of the business–health literature reveals that business research focuses primarily on occupational health and safety, health care organizations, and health regulations. To embrace the health externalities generated by business activities, we propose that future research should investigate the conditions under which business (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Genetic information, insurance and a pluralistic approach to justice.Jonathan Pugh - 2021 - Journal of Medical Ethics 47 (7):473-479.
    The use of genetic testing has prompted the question of whether insurance companies should be able to use predictive genetic test results (GTRs) in their risk classification of clients. While some jurisdictions have passed legislation to prohibit this practice, the UK has instead adopted a voluntary code of practice that merely restricts the ways in which insurance companies may use GTRs. Critics have invoked various theories of justice to argue that this approach is unfair. However, as well as sometimes relying (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Direct-to-Consumer Genetic Testing and Its Marketing: Emergent Ethical and Public Policy Implications.Alexander Nill & Gene Laczniak - 2020 - Journal of Business Ethics 175 (4):669-688.
    This paper provides a marketing ethics analysis that addresses the practice of selling genetic tests directly to the consumer. It details the complexity of this emergent sector by articulating the panoply of evolving ethical/social questions raised by this development. It advances the conversation about DTC genetic testing by reviewing the business and healthcare literature concerning this topic and by laying out the inherent ethical complications for consumers, marketers, and regulators. It also points to several possible public and company policy adjustments. (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The Role of Exceptionalism in the Evolution of Bioethical Regulation.Sergei Shevchenko & Alexey Zhavoronkov - 2024 - Cambridge Quarterly of Healthcare Ethics 33 (2):185-197.
    The paper aims to present a critical analysis of the phenomenon and notion of exceptionalism in bioethics. The authors demonstrate that exceptionalism pertains to phenomena that are not (yet) entirely familiar to us and could potentially bear risks regarding their regulation. After an overview of the state of the art, we briefly describe the origins and evolution of the concept, compared to exception and exclusion. In the second step, they look at the overall development debates on genetic exceptionalism, compared to (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Highway to (Digital) Surveillance: When Are Clients Coerced to Share Their Data with Insurers?Michele Loi, Christian Hauser & Markus Christen - 2020 - Journal of Business Ethics 175 (1):7-19.
    Clients may feel trapped into sharing their private digital data with insurance companies to get a desired insurance product or premium. However, private insurance must collect some data to offer products and premiums appropriate to the client’s level of risk. This situation creates tension between the value of privacy and common insurance business practice. We argue for three main claims: first, coercion to share private data with insurers is pro tanto wrong because it violates the autonomous choice of a privacy-valuing (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Anti-Selection & Genetic Testing in Insurance: An Interdisciplinary Perspective.Dexter Golinghorst, Aisling de Paor, Yann Joly, Angus S. Macdonald, Margaret Otlowski, Richard Peter & Anya E. R. Prince - 2022 - Journal of Law, Medicine and Ethics 50 (1):139-154.
    Anti-selection occurs when information asymmetry exists between insurers and applicants. When an applicant knows they are at high risk of loss, but the insurer does not, the applicant may try to use this knowledge differential to secure insurance at a lower premium that does not match risk.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The State of Ohio’s Auditors, the Enumeration of Population, and the Project of Eugenics.Cameron Graham, Martin E. Persson, Vaughan S. Radcliffe & Mitchell J. Stein - 2023 - Journal of Business Ethics 187 (3):565-587.
    In 1856, the State of Ohio began an enumeration of its population to count and identify people with disabilities. This paper examines the ethical role of the accounting profession in this project, which supported the transatlantic eugenics movement and its genocidal attempts to eliminate disabled persons from the population. We use a theoretical approach based on Levinas who argued that the self is generated through engagement with the Other, and that this engagement presupposes a responsibility to and for the Other. (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Genetic information, discrimination, philosophical pluralism and politics.Søren Holm - 2021 - Journal of Medical Ethics 47 (7):480-481.
    In the paper ‘Genetic information, insurance, and a pluralistic approach to justice’, Jonathan Pugh1 develops an argument from unresolved pluralism in our theories of justice, via the pluralism this occasions in relation to the specific question of the use of genetic test results in insurance underwriting, to the conclusion that the UK regulatory approach in relation to the use of GTRs in insurance is broadly correct.1 Pugh’s argument is wide-ranging and I cannot provide a complete critique of it in this (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation